GALT
GALECTIN THERAPEUTICS INC
Company overview
- Market capitalization
- $396.34M
- Employees
- 9
- Latest publication
- 2026-09-29
About GALECTIN THERAPEUTICS INC
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in drug development to create new therapies for fibrotic disease and cancer. The company's lead product candidate is belapectin (GR-MD-02), a galectin-3 inhibitor, which is in a Phase 2 clinical study in MASH patients with advanced fibrosis and a second Phase 2b clinical trial in MASH patients with compensated cirrhosis and portal hypertension. It has a joint venture co-owned by SBH Sciences, Inc. to research and develop small organic molecule inhibitors of galectin-3 for oral administration. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 36,000USD | 0USD | 0USD |
| Cost Of Revenue | 12,000USD | -12,000USD | — | 2,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD |
| Gross Profit | -12,000USD | 12,000USD | — | -2,000USD | -10,000USD | -10,000USD | -9,000USD | -9,000USD |
| Research Development | 2,231,000USD | 1,933,000USD | 2,611,000USD | 3,261,000USD | 6,485,000USD | 11,109,000USD | 7,595,000USD | 9,813,000USD |
| Selling General Administrative | 1,846,000USD | 1,432,000USD | 1,587,000USD | 1,364,000USD | 1,412,000USD | 1,319,000USD | 1,471,000USD | 1,478,000USD |
| Total Operating Expenses | 4,077,000USD | 3,365,000USD | 4,198,000USD | 4,625,000USD | 7,897,000USD | 12,428,000USD | 9,066,000USD | 11,291,000USD |
| Operating Income | -4,077,000USD | -3,365,000USD | -4,198,000USD | -4,625,000USD | -7,897,000USD | -12,428,000USD | -9,066,000USD | -11,291,000USD |
| Interest Income | 36,000USD | 25,000USD | 39,000USD | 26,000USD | 35,000USD | 84,000USD | 93,000USD | 80,000USD |
| Interest Expense | 1,988,000USD | 1,939,000USD | 1,820,000USD | 1,826,000USD | 1,744,000USD | 1,725,000USD | 1,494,000USD | 1,269,000USD |
| Net Interest Income | -1,952,000USD | -1,914,000USD | -1,781,000USD | -1,800,000USD | -1,709,000USD | -1,641,000USD | -1,401,000USD | -1,189,000USD |
| Income Before Tax | -5,046,000USD | -5,500,000USD | -8,184,000USD | -7,521,000USD | -9,631,000USD | -11,967,000USD | -11,220,000USD | -12,371,000USD |
| Net Income | -5,046,000USD | -5,500,000USD | -8,184,000USD | -7,521,000USD | -9,631,000USD | -11,967,000USD | -11,220,000USD | -12,371,000USD |
| Net Income From Continuing Ops | -5,046,000USD | -5,500,000USD | -8,184,000USD | -7,521,000USD | -9,631,000USD | -11,967,000USD | -11,220,000USD | -12,371,000USD |
| Ebit | -4,077,000USD | -3,561,000USD | — | -5,695,000USD | -7,887,000USD | -10,242,000USD | -9,726,000USD | -11,102,000USD |
| Ebitda | -4,065,000USD | -3,520,000USD | -6,364,000USD | -5,693,000USD | -7,877,000USD | -10,232,000USD | -9,717,000USD | -11,093,000USD |
| Depreciation And Amortization | 12,000USD | 41,000USD | — | 2,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD |
| Reconciled Depreciation | 12,000USD | 41,000USD | 0USD | 2,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD |
| Total Other Income Expense Net | -969,000USD | -2,135,000USD | -3,986,000USD | -2,896,000USD | -1,734,000USD | 461,000USD | -2,154,000USD | -1,080,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 9,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | 14,290,000USD | 36,571,000USD | 32,130,000USD | 31,737,000USD | 23,818,000USD | 17,976,000USD | 7,467,000USD | 6,471,000USD |
| Selling General Administrative | 5,795,000USD | 5,862,000USD | 5,942,000USD | 6,615,000USD | 6,361,000USD | 5,468,000USD | 5,971,000USD | 7,131,000USD |
| Total Operating Expenses | 20,085,000USD | 42,433,000USD | 38,072,000USD | 38,352,000USD | 30,179,000USD | 23,444,000USD | 13,438,000USD | 13,602,000USD |
| Operating Income | -20,085,000USD | -42,433,000USD | -38,072,000USD | -38,352,000USD | -30,179,000USD | -23,444,000USD | -13,438,000USD | -13,602,000USD |
| Interest Income | 126,000USD | 338,000USD | 186,000USD | 52,000USD | 3,000USD | 66,000USD | 231,000USD | 38,000USD |
| Interest Expense | 7,329,000USD | 5,540,000USD | 2,792,000USD | 1,033,000USD | 489,000USD | 87,000USD | 87,000USD | 336,000USD |
| Net Interest Income | -7,203,000USD | -5,202,000USD | -2,067,000USD | -981,000USD | -486,000USD | -21,000USD | 144,000USD | -298,000USD |
| Income Before Tax | -30,836,000USD | -47,047,000USD | -41,066,000USD | -38,776,000USD | -30,527,000USD | -23,465,000USD | -13,294,000USD | -13,900,000USD |
| Net Income | -30,836,000USD | -47,047,000USD | -41,066,000USD | -38,776,000USD | -30,527,000USD | -23,465,000USD | -13,294,000USD | -13,900,000USD |
| Net Income From Continuing Ops | -30,836,000USD | -47,047,000USD | -41,703,000USD | -38,776,000USD | -30,527,000USD | -23,465,000USD | -13,294,000USD | -13,900,000USD |
| Ebit | -23,507,000USD | -41,507,000USD | -38,274,000USD | -37,743,000USD | -30,038,000USD | -23,378,000USD | -13,207,000USD | -13,565,000USD |
| Ebitda | -23,454,000USD | -41,470,000USD | -38,241,000USD | -37,711,000USD | -29,997,000USD | -23,342,000USD | -13,172,000USD | -13,564,000USD |
| Depreciation And Amortization | 53,000USD | 37,000USD | 33,000USD | 32,000USD | 41,000USD | 36,000USD | 35,000USD | 1,000USD |
| Reconciled Depreciation | 53,000USD | 37,000USD | 32,000USD | 32,000USD | 41,000USD | 36,000USD | 35,000USD | 0USD |
| Total Other Income Expense Net | -10,751,000USD | -4,614,000USD | -2,994,000USD | -424,000USD | -348,000USD | -21,000USD | 144,000USD | -298,000USD |
| Cost Of Revenue | — | 37,000USD | 33,000USD | 32,000USD | 41,000USD | 36,000USD | 35,000USD | 1,000USD |
| Gross Profit | — | -37,000USD | -33,000USD | -32,000USD | -41,000USD | -36,000USD | -35,000USD | -1,000USD |
| Selling And Marketing Expenses | — | — | 44,000USD | — | — | — | — | — |
| Income Tax Expense | — | — | -2,994,000USD | 424,000USD | 448,000USD | 51,000USD | 87,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | — | -38,873,000USD | -30,698,000USD | -23,602,000USD | -20,179,000USD | -15,047,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 66,000USD | 231,000USD | 38,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 14,826,000USD | 15,759,000USD | 19,532,000USD | 12,865,000USD | 15,602,000USD | 9,528,000USD | 17,495,000USD | 28,972,000USD |
| Cash And Equivalents | 13,269,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 14,659,000USD | 15,691,000USD | 19,436,000USD | 12,729,000USD | 15,427,000USD | 9,285,000USD | 17,252,000USD | 28,666,000USD |
| Other Current Assets | 1,390,000USD | 1,580,000USD | 1,716,000USD | 1,204,000USD | 1,656,000USD | 1,854,000USD | 2,132,000USD | 1,606,000USD |
| Other Non Current Assets | 167,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 151,678,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 151,619,000USD | 7,307,000USD | 8,030,000USD | 136,445,000USD | 10,774,000USD | 110,840,000USD | 35,409,000USD | 25,258,000USD |
| Other Current Liabilities | 3,993,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 59,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | -138,575,000USD | -130,237,000USD | -126,195,000USD | -125,303,000USD | -117,167,000USD | -112,261,000USD | -103,070,000USD | -92,481,000USD |
| Total Equity Including Noncontrolling Interest | -136,852,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 118,000USD | — | 0USD | — | — | — | 0USD | — |
| Accounts Payable | 3,727,000USD | 3,121,000USD | 3,245,000USD | 5,390,000USD | 5,865,000USD | 6,534,000USD | 5,656,000USD | 2,795,000USD |
| Short Term Debt | 59,000USD | 6,000USD | 22,000USD | 122,312,000USD | 52,000USD | 97,174,000USD | 21,136,000USD | 10,550,000USD |
| Common Stock | 66,000USD | 65,000USD | 65,000USD | 64,000USD | 63,000USD | 63,000USD | 62,000USD | 62,000USD |
| Retained Earnings | -446,788,000USD | -437,613,000USD | -432,546,000USD | -426,984,000USD | -418,761,000USD | -411,177,000USD | -401,572,000USD | -389,542,000USD |
| Total Liab | — | 145,996,000USD | 145,727,000USD | 138,168,000USD | 132,769,000USD | 121,789,000USD | 120,565,000USD | 121,453,000USD |
| Other Current Liab | — | 4,180,000USD | 4,763,000USD | 8,743,000USD | 4,857,000USD | 7,132,000USD | 8,617,000USD | 11,913,000USD |
| Capital Stock | — | 2,268,000USD | 2,278,000USD | 554,000USD | 2,276,000USD | 2,286,000USD | 2,285,000USD | 2,285,000USD |
| Cash | — | 14,111,000USD | 17,720,000USD | 11,525,000USD | 13,771,000USD | 7,431,000USD | 15,120,000USD | 27,060,000USD |
| Cash And Short Term Investments | — | 14,111,000USD | 17,720,000USD | 11,525,000USD | 13,771,000USD | 7,431,000USD | 15,120,000USD | 27,060,000USD |
| Net Debt | — | 121,599,000USD | 116,015,000USD | 110,787,000USD | 106,739,000USD | 100,556,000USD | 91,125,000USD | 77,526,000USD |
| Short Long Term Debt Total | — | 135,710,000USD | 133,735,000USD | 122,312,000USD | 120,510,000USD | 107,987,000USD | 106,245,000USD | 104,586,000USD |
| Long Term Debt | — | 135,710,000USD | 133,735,000USD | — | 120,458,000USD | 10,813,000USD | 85,109,000USD | 94,036,000USD |
| Common Stock Shares Outstanding | — | 65,782,000shares | 63,903,000shares | 64,205,000shares | 63,447,000shares | 63,204,000shares | 62,739,795shares | 62,278,000shares |
| Non Current Assets Total | — | 68,000USD | 96,000USD | 136,000USD | 175,000USD | 243,000USD | 243,000USD | 306,000USD |
| Non Current Liabilities Total | — | 138,689,000USD | 137,697,000USD | 1,723,000USD | 121,995,000USD | 10,949,000USD | 85,156,000USD | 96,195,000USD |
| Non Currrent Assets Other | — | 68,000USD | 96,000USD | 136,000USD | 175,000USD | 243,000USD | 243,000USD | 306,000USD |
| Net Working Capital | — | 8,384,000USD | 11,406,000USD | -123,716,000USD | 4,653,000USD | -101,555,000USD | -18,157,000USD | 3,408,000USD |
| Unclassified Non Current Liabilities | — | 2,979,000USD | 3,962,000USD | 1,723,000USD | 1,537,000USD | — | — | 2,159,000USD |
| Unclassified Equity | — | 305,043,000USD | 304,008,000USD | 301,063,000USD | 299,255,000USD | 296,567,000USD | 296,155,000USD | 294,714,000USD |
| Property Plant Equipment Gross | — | — | 74,000USD | — | — | — | 74,000USD | — |
| Short Long Term Debt | — | — | — | 122,275,000USD | — | 97,106,000USD | 21,117,000USD | 10,518,000USD |
| Unclassified Current Liabilities | — | — | — | -122,275,000USD | — | -97,106,000USD | -21,117,000USD | -10,518,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 19,532,000USD | 17,495,000USD | 28,200,000USD | 21,285,000USD | 41,827,000USD | 29,600,000USD | 48,467,000USD | 9,006,000USD |
| Other Current Assets | 1,716,000USD | 2,132,000USD | 2,050,000USD | 1,960,000USD | 2,172,000USD | 2,323,000USD | 729,000USD | 1,152,000USD |
| Total Liab | 145,727,000USD | 120,565,000USD | 88,441,000USD | 53,479,000USD | 39,211,000USD | 5,407,000USD | 2,872,000USD | 2,108,000USD |
| Total Stockholder Equity | -126,195,000USD | -103,070,000USD | -60,241,000USD | -32,194,000USD | 2,616,000USD | 24,193,000USD | 45,595,000USD | 6,898,000USD |
| Other Current Liab | 4,763,000USD | 8,617,000USD | 9,199,000USD | 9,082,000USD | 7,220,000USD | 4,063,000USD | 1,120,000USD | 1,811,000USD |
| Common Stock | 65,000USD | 62,000USD | 61,000USD | 59,000USD | 59,000USD | 56,000USD | 56,000USD | 41,000USD |
| Capital Stock | 2,278,000USD | 2,285,000USD | 2,284,000USD | 2,292,000USD | 2,309,000USD | 2,306,000USD | 2,316,000USD | 8,983,000USD |
| Retained Earnings | -432,546,000USD | -401,572,000USD | -354,372,000USD | -309,567,000USD | -270,694,000USD | -239,996,000USD | -216,394,000USD | -196,215,000USD |
| Cash | 17,720,000USD | 15,120,000USD | 25,660,000USD | 18,592,000USD | 39,648,000USD | 27,142,000USD | 47,480,000USD | 8,253,000USD |
| Cash And Short Term Investments | 17,720,000USD | 15,120,000USD | 25,660,000USD | 18,592,000USD | 39,648,000USD | 27,142,000USD | 47,480,000USD | 8,253,000USD |
| Total Current Assets | 19,436,000USD | 17,252,000USD | 27,710,000USD | 20,552,000USD | 41,820,000USD | 29,465,000USD | 48,209,000USD | 8,832,000USD |
| Total Current Liabilities | 8,030,000USD | 35,409,000USD | 15,676,000USD | 13,012,000USD | 9,033,000USD | 5,399,000USD | 2,820,000USD | 2,108,000USD |
| Net Debt | 116,015,000USD | 91,125,000USD | 46,147,000USD | 21,276,000USD | -10,592,000USD | -27,098,000USD | -47,441,000USD | -8,253,000USD |
| Short Term Debt | 22,000USD | 21,136,000USD | 46,000USD | 40,000USD | 8,000USD | 44,000USD | 39,000USD | — |
| Short Long Term Debt Total | 133,735,000USD | 106,245,000USD | 71,807,000USD | 39,868,000USD | 29,056,000USD | 44,000USD | 39,000USD | — |
| Long Term Debt | 133,735,000USD | 85,109,000USD | 71,741,000USD | 39,828,000USD | 29,048,000USD | — | — | — |
| Accounts Payable | 3,245,000USD | 5,656,000USD | 6,431,000USD | 3,890,000USD | 1,805,000USD | 1,292,000USD | 1,661,000USD | 297,000USD |
| Property Plant Equipment Net | 0USD | 0USD | 53,000USD | 733,000USD | 7,000USD | 135,000USD | 258,000USD | 174,000USD |
| Property Plant Equipment Gross | 74,000USD | 74,000USD | 74,000USD | 807,000USD | 81,000USD | 209,000USD | 332,000USD | — |
| Common Stock Shares Outstanding | 63,903,000shares | 62,309,000shares | 60,159,000shares | 59,391,000shares | 58,527,000shares | 57,029,000shares | 52,238,000shares | 39,414,000shares |
| Non Current Assets Total | 96,000USD | 243,000USD | 490,000USD | 733,000USD | 7,000USD | 135,000USD | 258,000USD | 174,000USD |
| Non Current Liabilities Total | 137,697,000USD | 85,156,000USD | 72,765,000USD | 40,467,000USD | 30,178,000USD | 8,000USD | 52,000USD | 0USD |
| Non Currrent Assets Other | 96,000USD | 243,000USD | 437,000USD | 733,000USD | 7,000USD | 135,000USD | 258,000USD | 174,000USD |
| Net Working Capital | 11,406,000USD | -18,157,000USD | 12,034,000USD | 7,540,000USD | 32,787,000USD | 24,066,000USD | 45,389,000USD | 6,724,000USD |
| Unclassified Non Current Liabilities | 3,962,000USD | — | 1,004,000USD | — | 1,130,000USD | — | — | — |
| Unclassified Equity | 304,008,000USD | 296,155,000USD | 291,786,000USD | 275,022,000USD | 270,942,000USD | 261,827,000USD | 259,691,000USD | 194,163,000USD |
| Current Deferred Revenue | — | -6,681,000USD | 63,000USD | — | — | — | — | — |
| Short Long Term Debt | — | 21,117,000USD | — | — | — | — | — | — |
| Unclassified Current Liabilities | — | -21,117,000USD | — | — | — | — | — | — |
| Other Assets | — | — | 1USD | 733,000USD | — | 135,000USD | 0USD | 174,000USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | — | 0USD | 0USD | -74,000USD | -74,000USD |
| Non Current Liabilities Other | — | — | 20,000USD | 66,000USD | — | 8,000USD | 52,000USD | — |
| Other Liab | — | — | — | 66,000USD | — | 8,000USD | 52,000USD | — |
| Net Tangible Assets | — | — | — | -34,427,000USD | 366,000USD | 21,943,000USD | 45,058,000USD | -321,000USD |
| Unclassified Non Current Assets | — | — | — | -1,466,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 1,649,000USD |
| Change To Liabilities | -190,000USD |
| Change In Working Capital | 24,000USD |
| Operating Cash Flow | -6,305,000USD |
| Financing Cash Flow | 1,854,000USD |
| Change In Cash | -4,451,000USD |
| End Cash Flow | 13,269,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,046,000USD | -5,500,000USD | -8,184,000USD | -7,521,000USD | -9,631,000USD | -11,967,000USD | -11,220,000USD | -12,371,000USD |
| Depreciation | 12,000USD | 41,000USD | 0USD | 2,000USD | 10,000USD | 10,000USD | 9,000USD | 9,000USD |
| Stock Based Compensation | 686,000USD | 195,000USD | 496,000USD | 500,000USD | 468,000USD | 590,000USD | 515,000USD | 738,000USD |
| Other Non Cash Items | -827,000USD | 403,000USD | 2,420,000USD | 1,445,000USD | 372,000USD | -1,750,000USD | 1,045,000USD | 141,000USD |
| Change In Working Capital | 1,309,000USD | -1,181,000USD | 1,726,000USD | -1,028,000USD | 1,092,000USD | 326,000USD | 1,113,000USD | 3,150,000USD |
| Total Cash From Operating Activities | -3,866,000USD | -6,042,000USD | -3,542,000USD | -6,602,000USD | -7,689,000USD | -12,791,000USD | -8,538,000USD | -8,333,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -3,866,000USD | -6,042,000USD | -3,542,000USD | -6,602,000USD | -7,689,000USD | -12,791,000USD | -8,538,000USD | -8,333,000USD |
| Total Cash From Financing Activities | 257,000USD | 12,237,000USD | 1,296,000USD | 12,942,000USD | 0USD | 851,000USD | 10,000,000USD | 10,376,000USD |
| Dividends Paid | -61,000USD | -62,000USD | -14,000USD | — | -62,000USD | -73,000USD | -18,000USD | — |
| Change In Cash | -3,609,000USD | 6,195,000USD | -2,246,000USD | 6,340,000USD | -7,689,000USD | -11,940,000USD | 1,462,000USD | 2,043,000USD |
| Begin Period Cash Flow | 17,720,000USD | 11,525,000USD | 13,771,000USD | 7,431,000USD | 15,120,000USD | 27,060,000USD | 25,598,000USD | 23,555,000USD |
| End Period Cash Flow | 14,111,000USD | 17,720,000USD | 11,525,000USD | 13,771,000USD | 7,431,000USD | 15,120,000USD | 27,060,000USD | 25,598,000USD |
| Other Cashflows From Financing Activities | 61,000USD | 62,000USD | 443,000USD | — | 62,000USD | 73,000USD | 18,000USD | 376,000USD |
| Net Borrowings | — | 10,000,000USD | 0USD | 11,000,000USD | 0USD | 0USD | 10,000,000USD | — |
| Sale Purchase Of Stock | — | 219,000USD | 213,000USD | — | — | — | 568,000USD | — |
| Issuance Of Capital Stock | — | 1,164,000USD | 853,000USD | — | — | — | 0USD | — |
| Unclassified Financing Cash Flow | — | 2,018,000USD | — | 1,942,000USD | — | — | — | 10,000,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -30,836,000USD | -47,047,000USD | -41,066,000USD | -38,776,000USD | -30,527,000USD | -23,465,000USD | -13,294,000USD | -13,900,000USD |
| Depreciation | 53,000USD | 37,000USD | 33,000USD | 32,000USD | 41,000USD | 36,000USD | 35,000USD | 1,000USD |
| Stock Based Compensation | 1,659,000USD | 2,447,000USD | 2,261,000USD | 2,867,000USD | 2,076,000USD | 1,799,000USD | 1,683,000USD | 4,445,000USD |
| Other Non Cash Items | 4,640,000USD | 512,000USD | 1,129,000USD | -147,000USD | 489,000USD | 87,000USD | 87,000USD | 348,000USD |
| Change In Working Capital | 609,000USD | 2,284,000USD | 4,678,000USD | 4,968,000USD | 3,751,000USD | 942,000USD | 641,000USD | -1,072,000USD |
| Total Cash From Operating Activities | -23,875,000USD | -41,767,000USD | -32,965,000USD | -31,056,000USD | -24,308,000USD | -20,601,000USD | -10,848,000USD | -10,179,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -23,875,000USD | -41,767,000USD | -32,965,000USD | -31,056,000USD | -24,308,000USD | -20,601,000USD | -10,848,000USD | -10,179,000USD |
| Net Borrowings | 21,000,000USD | 30,000,000USD | 30,000,000USD | 10,000,000USD | 30,000,000USD | 30,000,000USD | 30,000,000USD | 30,000,000USD |
| Total Cash From Financing Activities | 26,475,000USD | 31,227,000USD | 40,033,000USD | 10,000,000USD | 36,814,000USD | 263,000USD | 50,075,000USD | 15,379,000USD |
| Dividends Paid | -138,000USD | -91,000USD | -120,000USD | -97,000USD | -171,000USD | -137,000USD | -394,000USD | -915,000USD |
| Sale Purchase Of Stock | 667,000USD | 845,000USD | 671,000USD | 899,000USD | -30,000,000USD | 263,000USD | 50,469,000USD | 15,379,000USD |
| Issuance Of Capital Stock | 3,235,000USD | 0USD | — | -1,000USD | 6,814,000USD | 263,000USD | 50,469,000USD | 15,379,000USD |
| Change In Cash | 2,600,000USD | -10,540,000USD | 7,068,000USD | -21,056,000USD | 12,506,000USD | -20,338,000USD | 39,227,000USD | 5,200,000USD |
| Begin Period Cash Flow | 15,120,000USD | 25,660,000USD | 18,592,000USD | 39,648,000USD | 27,142,000USD | 47,480,000USD | 8,253,000USD | 3,053,000USD |
| End Period Cash Flow | 17,720,000USD | 15,120,000USD | 25,660,000USD | 18,592,000USD | 39,648,000USD | 27,142,000USD | 47,480,000USD | 8,253,000USD |
| Other Cashflows From Financing Activities | 138,000USD | 91,000USD | 10,033,000USD | 8,299,000USD | 30,171,000USD | 137,000USD | -394,000USD | 915,000USD |
| Unclassified Financing Cash Flow | 4,808,000USD | — | — | -9,101,000USD | 6,814,000USD | -30,000,000USD | -29,606,000USD | -30,000,000USD |
| Investments | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Change To Liabilities | — | — | — | 4,244,000USD | 3,686,000USD | 2,536,000USD | 997,000USD | -1,091,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | — | -20,338,000USD | 39,227,000USD | 5,200,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.